• Profile
Close

First‐trimester maternal folic acid supplementation reduced risks of severe and most congenital heart diseases in offspring: A large case‐control study

Journal of the American Heart Association Jul 10, 2020

Qu Y, Lin S, Zhuang J, et al. - Among 8,379 confirmed congenital heart disease (CHD) cases and 6,918 controls from 40 healthcare centers of 21 cities in Guangdong Province, China, researchers conducted this case‐control study to evaluate the individual and joint impact of first‐trimester maternal folic acid supplementation (FAS) and multivitamin use on CHDs in offspring. According to findings, first‐trimester maternal FAS was substantially correlated with a lower risk of CHDs but not multivitamin use, and the relationship was strongest for the most severe CHD phenotypes. It is recommended that women of childbearing age supplement folic acid as soon as possible, ensuring coverage of the critical window for fetal cardiac development to prevent CHDs.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay